Table 4.
Most Frequently Reported Adverse Events (Safety Population)
| Adverse Eventsa | Patients (N = 29), n (%) |
|---|---|
| Diarrhea | 21 (72) |
| Tremor | 11 (38) |
| Abdominal pain | 10 (34) |
| Cough | 10 (34) |
| Pyrexia | 8 (28) |
| Weight decreased | 7 (24) |
| Nasopharyngitis | 7 (24) |
| Vomiting | 6 (21) |
| Convulsions | 6 (21) |
| Headache | 6 (21) |
| Activated partial thromboplastin time prolonged | 6 (21) |
| Aspartate aminotransferase increased | 6 (21) |
aAdverse events that occurred in at least 20% of patients.